Ischemic heart diseases often referred to as coronary artery disease, occur when blood flow to the heart is reduced due to narrowed or blocked coronary arteries. This restriction, usually caused by atherosclerosis, deprives the heart muscle of oxygen and nutrients, leading to symptoms like chest pain (angina), fatigue, and shortness of breath. Severe or prolonged ischemia can result in a heart attack, posing life-threatening risks. Managing ischemic heart diseases involves lifestyle changes, medications to improve blood flow, and medical interventions like stenting or bypass surgery. Early diagnosis and treatment play a vital role in preventing complications and improving long-term cardiac health. With ongoing advancements in cardiology, innovative therapies are offering patients new opportunities for recovery and improved quality of life.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation